Nimbus initiates Phase I clinical programme for NDI-010976 for the treatment of NASH
22 April 2015 | By Victoria White
Nimbus Therapeutics has initiated a Phase I clinical programme for NDI-010976 for the treatment of NASH and related fatty liver disease-spectrum disorders...